Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)

Market Cap	4.29B -4.3%
Revenue (ttm)	7.25B -5.9%
Net Income	14.35M +55.8%
EPS	0.01 +19.5%
Shares Out	1.47B
PE Ratio	299.04
Forward PE	n/a
Dividend	0.00 (0.07%)
Ex-Dividend Date	n/a

Volume	22,682,100
Open	2.860
Previous Close	2.940
Day's Range	2.860 - 2.950
52-Week Range	2.770 - 4.690
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHE:002589

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materials, herbal medicine, and patent medicine. It is also involved in the wholesale of biochemical, psychotropic, narcotic, and toxic drugs for medical use...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2004
• Employees: 2,407
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002589

Financial Performance

In 2025, SHE:002589's revenue was 7.30 billion, a decrease of -8.42% compared to the previous year's 7.97 billion. Earnings were 16.07 million, an increase of 30.73%.